300 related articles for article (PubMed ID: 35223745)
21. Evaluating the Effects of Curcumin on the Cytokine Storm in COVID-19 Using a Chip-Based Multiplex Analysis.
Zahedipour F; Guest PC; Majeed M; Moallem SA; Kesharwani P; Jamialahmadi T; Sahebkar A
Methods Mol Biol; 2022; 2511():285-295. PubMed ID: 35838968
[TBL] [Abstract][Full Text] [Related]
22. Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab.
Dolinger MT; Person H; Smith R; Jarchin L; Pittman N; Dubinsky MC; Lai J
J Pediatr Gastroenterol Nutr; 2020 Aug; 71(2):153-155. PubMed ID: 32452979
[TBL] [Abstract][Full Text] [Related]
23. The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation.
Wang J; Kaplan N; Wysocki J; Yang W; Lu K; Peng H; Batlle D; Lavker RM
FASEB J; 2020 Aug; 34(8):10505-10515. PubMed ID: 32725927
[TBL] [Abstract][Full Text] [Related]
24. Low dose radiation therapy attenuates ACE2 depression and inflammatory cytokines induction by COVID-19 viral spike protein in human bronchial epithelial cells.
Wen K; Bai C; Zhao H; Zhou P; Gao S; Guan H; Song M
Int J Radiat Biol; 2022; 98(10):1532-1541. PubMed ID: 35319335
[No Abstract] [Full Text] [Related]
25. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
26. A Specific Pattern and Dynamics of Circulating Cytokines Are Associated with the Extension of Lung Injury and Mortality in Colombian Adults with Coronavirus Disease-19.
Bolívar-Marín S; Castro M; Losada-Floriano D; Cortés S; Perdomo-Celis F; Lastra G; Narváez CF
J Interferon Cytokine Res; 2023 May; 43(5):206-215. PubMed ID: 37103589
[TBL] [Abstract][Full Text] [Related]
27. A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.
Rehan M; Ahmed F; Howladar SM; Refai MY; Baeissa HM; Zughaibi TA; Kedwa KM; Jamal MS
Front Immunol; 2021; 12():648250. PubMed ID: 34248936
[TBL] [Abstract][Full Text] [Related]
28. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
30. Blocking TNF signaling may save lives in COVID-19 infection.
Ablamunits V; Lepsy C
Mol Biol Rep; 2022 Mar; 49(3):2303-2309. PubMed ID: 35076845
[TBL] [Abstract][Full Text] [Related]
31. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
[TBL] [Abstract][Full Text] [Related]
32. Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management.
Mohd Zawawi Z; Kalyanasundram J; Mohd Zain R; Thayan R; Basri DF; Yap WB
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047115
[TBL] [Abstract][Full Text] [Related]
33. JAK inhibition as a new treatment strategy for patients with COVID-19.
Huang J; Zhou C; Deng J; Zhou J
Biochem Pharmacol; 2022 Aug; 202():115162. PubMed ID: 35787993
[TBL] [Abstract][Full Text] [Related]
34. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
[TBL] [Abstract][Full Text] [Related]
35. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
36. Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
Solimani F; Meier K; Ghoreschi K
Eur J Immunol; 2021 May; 51(5):1071-1075. PubMed ID: 33675065
[TBL] [Abstract][Full Text] [Related]
37. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1.
Kandhaya-Pillai R; Yang X; Tchkonia T; Martin GM; Kirkland JL; Oshima J
Aging Cell; 2022 Jun; 21(6):e13646. PubMed ID: 35645319
[TBL] [Abstract][Full Text] [Related]
38. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
39. Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics.
Sapra L; Saini C; Garg B; Gupta R; Verma B; Mishra PK; Srivastava RK
Inflamm Res; 2022 Sep; 71(9):1025-1040. PubMed ID: 35900380
[TBL] [Abstract][Full Text] [Related]
40. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α.
Frisoni P; Neri M; D'Errico S; Alfieri L; Bonuccelli D; Cingolani M; Di Paolo M; Gaudio RM; Lestani M; Marti M; Martelloni M; Moreschi C; Santurro A; Scopetti M; Turriziani O; Zanon M; Scendoni R; Frati P; Fineschi V
Forensic Sci Med Pathol; 2022 Mar; 18(1):4-19. PubMed ID: 34463916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
